New appointment for Debbie Rigby


Leading pharmacist to head Lung Foundation Australia committee

The Lung Foundation Australia has announced that Debbie Rigby has been appointed as the Chronic Obstructive Pulmonary Disease (COPD) Pharmacy Committee Chair.

“Debbie is a longstanding member of the committee and has actively engaged with the Lung Foundation for many years, including being the face of our inhaler device technique videos,” the organisation said.

“As an advanced practice pharmacist with postgraduate qualifications in clinical pharmacy, geriatrics and respiratory medicine, Debbie brings a wealth of knowledge and experience to the position”.

Ms Rigby is currently a director of NPS MedicineWise and is a past Vice-President of the Pharmaceutical Society of Australia (PSA). She currently works in a general practice, conducts Home Medicine Reviews and provides medicines education to pharmacists, nurses, GPs and other health professionals through her company Pharmeducation.

For her passion and commitment to the pharmacy profession and quality use of medicines, Debbie has received numerous awards including PSA Pharmacist of the Year, the inaugural AACP Consultant Pharmacist of the Year, and SHPA Clinical Pharmacy Award.

The Lung Foundation also issued “a heartfelt thank you to the outgoing Chair, Peter Guthrey for his enormous contribution to the Lung Foundation over the past decade”.

“Peter has been a member of the COPD Coordinating Committee for the last nine years, and was an inaugural member of the COPD Pharmacy Committee which was formed to develop online COPD training for pharmacists. He took over as Chair of the COPD Pharmacy Committee three years ago and has led this group to successfully increasing the profile of the Lung Foundation in the pharmacy community.

Thank you Peter for making a significant contribution to the COPD National Program”.

Debbie Rigby was recently chosen by AJP readers as one of the 12 Agenda Setters of pharmacy

Previous ‘It is time for FIP to rethink its role.’
Next Celebrating innovation

NOTICE: It can sometimes take awhile for comment submissions to go through, please be patient.